Optune Lua's position in the market will be more clear after Novocure unveils the results of a study testing the device with ...

3, shares of Novocure rose 112% higher. They've been soaring because, in addition to positive pancreatic cancer results, its Optune Lua device earned approval to treat lung cancer patients in October.

Do not use any parts that did not come with the Optune Gio Treatment Kit sent to you by Novocure or given to you by your doctor Do not get the device or transducer arrays wet If you have an ...

Detailed price information for Zai Lab Ltd ADR (ZLAB-Q) from The Globe and Mail including charting and trades.

According to Novocure, in the case of Optune Gio, the TTFields are intended ... was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this ...

Novocure plans to convert Optune Gio users in the U.S. to the new HFE arrays through the first half of 2025 through a controlled transition plan. Optune Gio is a wearable, portable, FDA-approved ...